About Kabir

Kabir Toor has nearly ten years of experience in systematic reviews and evidence synthesis specializing in leading large, multidisciplinary teams and integrating complex survival modelling to support an array of market access objectives. At Precision, Kabir has supported drug reimbursement submissions in North American, European, and Asian markets with a focus on complex survival modelling in the field of oncology. He has also supported methods development and clinical research by publishing in a variety of high impact journals. Prior to joining Precision, Kabir supported running of a large multi-site randomized clinical trial and was involved in both Hepatitis C and HIV guideline development for the World Health Organization.

EDUCATION:
BHSc, University of Ottawa
MPH, University of British Columbia